Selexys Pharmaceuticals
Selexys develops novel therapeutics for the treatment of inflammatory and thrombotic diseases.
Business Model:
Revenue: $8.5M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Selexys Pharmaceuticals Information
Selexys Pharmaceuticals was acquired by
Novartis.
The acquisition happend on 2016-11-21.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 840 Research Pkwy
City: Oklahoma City
State: OK
Zip: 73104
Country: US
Financial Info
Stage:
series b
Raised Last:
$43M
Raised Total:$52M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Selexys develops novel therapeutics for the treatment of inflammatory and thrombotic diseases.
Contact Phone:
+14053198195
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2010 | Debt | $5M | 1/2009 | Seed Round | 2 | - |
i2E Oklahoma Seed Capital Fund i2E Oklahoma Seed Capital Fund |
9/2012 | Series A | 1 | $23M |
MPM Capital MPM Capital |
7/2009 | Debt Financing | $3.4M | 9/2012 | Series A | $43.2M | 8/2008 | Debt | $3.4M | 11/2011 | Debt Financing | $5M | 2/2015 | Series B | $43.2M | 1/2009 | Seed Round | 2 | - |
i2E Oklahoma Seed Capital Fund i2E Oklahoma Seed Capital Fund |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
